Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinolipid vs Intralipid in Pediatric Patients Requiring Parenteral Nutrition
NCT04555044Phase 4Completed
- Sponsor
- Baxter
- Start
- Jan 2021
- Primary completion
- Oct 2022
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of soybean oil emulsion in essential fatty acid deficiency (EFAD) (2 arms), sponsored by Baxter. Primary endpoint: Number of Participants to Develop Essential Fatty Acid Deficiency. Started Jan 2021; status: completed.
02
Drugs
soybean oil emulsion
03
Conditions
essential fatty acid deficiency (EFAD)
Beyond the preview
Go deeper on NCT04555044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04555044.